Article Information
History
- July 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Takuya Tada1,*,
- Hao Zhou1,*,
- Belinda M. Dcosta1,
- Marie I. Samanovic2,
- Mark J. Mulligan2 and
- Nathaniel R. Landau1,**
- 1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
- 2NYU Langone Vaccine Center and Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
- ↵**Corresponding author: Nathaniel R. Landau, Ph.D., NYU Grossman School of Medicine, 430 East 29th Street, Alexandria West Building, Rm 509, New York, NY 10016, Email: nathaniel.landau{at}med.nyu.edu, Phone: (212) 263-9197
↵* Contributed equally to this study
Posted July 03, 2021.
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
